Why Are EyePoint Pharmaceuticals Shares Trading Higher Today

EyePoint Pharmaceuticals Inc EYPT shares are trading higher after the company appointed Jay Duker as chief executive officer, transitioning from his most recent role as chief operating officer and president. 

Duker has also been appointed to the company's Board of Directors, effective today. 

Nancy Lurker has transitioned to executive vice chair of the Board of Directors from the position of CEO.

"Serving as CEO of EyePoint Pharmaceuticals these past seven years has been an exciting journey, and I am immensely proud of what our team has accomplished to create a brighter future for patients at risk of losing their sight," Lurker said. 

EyePoint Pharmaceuticals is a commercial-stage company on eye disorders.

Price Action: EYPT shares are up 9.13% at $8.77 on the last check Monday.

Now Read: The iPhone 15 Pro Max May Burn A Bigger Hole In Your Pocket Because Of This New Camera Feature